SCOPUS 정보 검색 플랫폼

Blood

Volumn 118, Issue 4, 2011, Pages 828-829

Childhood T-ALL: It's time to move on

(2) Whitlock, James A a,b Silverman, Lewis B a,b

a Hospital for Sick Children (United States)

b DANA FARBER CANCER INSTITUTE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GAMMA SECRETASE; METHOTREXATE; NELARABINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER CHEMOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CHILDHOOD CANCER; DRUG MEGADOSE; ENZYME INHIBITION; HUMAN; LEUKEMOGENESIS; LEUKOCYTE COUNT; NEUROTOXICITY; NONHODGKIN LYMPHOMA; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SIDE EFFECT; SKULL IRRADIATION; TREATMENT PLANNING;

EID: 79960974255 PISSN: 00064971 EISSN: 15280020 Source Type: Journal
DOI: 10.1182/blood-2011-05-348375 Document Type: Note

Times cited : (3)

References (10)

1
- 79961016780
- Effectiveness of high dose methotrexate in T-cell lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: A randomized study by the Children's Oncology Group (POG 9404)
- Asselin BL, Devidas M, Wang C, et al. Effectiveness of high dose methotrexate in T-cell lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404). Blood. 2011;118(4):874-883.
- (2011) Blood , vol.118 , Issue.4 , pp. 874-883
- Asselin, B.L.¹ Devidas, M.² Wang, C.³

2
- 0028152851
- Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86
- Reiter A, Schrappe M, Ludwig W-D, et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood. 1994;84(9):3122-3133. (Pubitemid 24328106)
- (1994) Blood , vol.84 , Issue.9 , pp. 3122-3133
- Reiter, A.¹ Schrappe, M.² Ludwig, W.-D.³ Hiddemann, W.⁴ Sauter, S.⁵ Henze, G.⁶ Zimmermann, M.⁷ Lampert, F.⁸ Havers, W.⁹ Niethammer, D.¹⁰ Odenwald, E.¹¹ Ritter, J.¹² Mann, G.¹³ Weite, K.¹⁴ Gadner, H.¹⁵ Riehm, H.¹⁶

3
- 0142008436
- Childhood T-cell acute lymphoblastic leukemia: The Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium experience
- DOI 10.1200/JCO.2003.10.116
- Goldberg JM, Silverman LB, Levy DE, et al. Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience. J Clin Oncol. 2003;21(19):3616-3622. (Pubitemid 46594054)
- (2003) Journal of Clinical Oncology , vol.21 , Issue.19 , pp. 3616-3622
- Goldberg, J.M.¹ Silverman, L.B.² Levy, D.E.³ Dalton, V.K.⁴ Gelber, R.D.⁵ Lehmann, L.⁶ Cohen, H.J.⁷ Sallan, S.E.⁸ Asselin, B.L.⁹

4
- 67649410242
- Treating childhood acute lymphoblastic leukemia without cranial irradiation
- Pui CH, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. New Engl J Med. 2009;360(26):2730-2741.
- (2009) New Engl J Med , vol.360 , Issue.26 , pp. 2730-2741
- Pui, C.H.¹ Campana, D.² Pei, D.³

5
- 70349192784
- Extended triple intrathecal therapy in children with T-cell acute lymphoblastic leukaemia: A report from the Israeli National ALL-Studies
- Stark B, Avrahami G, Nirel R, et al. Extended triple intrathecal therapy in children with T-cell acute lymphoblastic leukaemia: a report from the Israeli National ALL-Studies. Br J Haematol. 2009;147(1):113-124.
- (2009) Br J Haematol , vol.147 , Issue.1 , pp. 113-124
- Stark, B.¹ Avrahami, G.² Nirel, R.³

6
- 20644464975
- Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: A report from the Children's Oncology Group
- Berg SL, Blaney SM, Devidas M, et al. Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: A report from the Children's Oncology Group. J Clin Oncol. 2005;23(15):3376-3382.
- (2005) J Clin Oncol , vol.23 , Issue.15 , pp. 3376-3382
- Berg, S.L.¹ Blaney, S.M.² Devidas, M.³

7
- 5044225888
- Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia
- DOI 10.1126/science.1102160
- Weng AP, Ferrando AA, Lee W, et al. Activating mutations of NOTCH1 in humanTcell acute lymphoblastic leukemia. Science. 2004;306(5694):269-271. (Pubitemid 39336870)
- (2004) Science , vol.306 , Issue.5694 , pp. 269-271
- Weng, A.P.¹ Ferrando, A.A.² Lee, W.³ Morris IV, J.P.⁴ Silverman, L.B.⁵ Sanchez-Irizarry, C.⁶ Blacklow, S.C.⁷ Look, A.T.⁸ Aster, J.C.⁹

8
- 34548592412
- A phase I clinical trial of the Notch1 inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) and other leukemias
- abstract. Abstract 6585
- DeAngelo DJ, Stone RM, Silverman LB, et al. A phase I clinical trial of the Notch1 inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) and other leukemias [abstract]. J Clin Oncol. 2006;24;357s. Abstract 6585.
- (2006) J Clin Oncol , vol.24
- DeAngelo, D.J.¹ Stone, R.M.² Silverman, L.B.³

9
- 58749095816
- Early T-cell precursor leukaemia: A subtype of very high-risk acute lymphoblastic leukaemia
- Coustan-Smith E, Mullighan CG, Onciu M, et al. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol. 2009;10(2):147-156.
- (2009) Lancet Oncol , vol.10 , Issue.2 , pp. 147-156
- Coustan-Smith, E.¹ Mullighan, C.G.² Onciu, M.³

10
- 78650068497
- Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance
- Chiu PP, Jiang H, Dick JE. Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance. Blood. 2010;116(24):5268-5279.
- (2010) Blood , vol.116 , Issue.24 , pp. 5268-5279
- Chiu, P.P.¹ Jiang, H.² Dick, J.E.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.